As part of our patient-forward mission, we strive to do our best to improve the lives of cancer patients.

As part of our patient-forward mission, we strive to do our best to improve the lives of cancer patients."

Asaf Danziger, Chief Executive Officer

we are dedicated to our mission of making TTFields available to all cancer patients who may benefit from it.

Over a decade ago, we joined Novocure for the opportunity to make a meaningful difference in the lives of cancer patients. Establishing, building and growing an innovative company to provide patients with a new cancer treatment modality demands determination, perseverance and an unwavering focus on the scientific evidence to keep moving forward regardless of the obstacles or resistance that may be encountered. We are passionate about bringing our therapy to all patients who may benefit from it and to developing TTFields for additional solid tumor cancers.

Bill Doyle, Executive Chairman

Bill Doyle, Executive Chairman

Asaf Danziger, Chief Executive Officer

Asaf Danziger, Chief Executive Officer

corporate officers and
executive leadership

William F. Doyle
Executive Chairman
Asaf Danziger
Chief Executive Officer
Mike Ambrogi
Chief Operating Officer
Wilco Groenhuysen
Chief Financial Officer
Eilon Kirson, M.D., Ph.D.
Chief Science Officer and Head of Research and Development
Todd Longsworth
General Counsel
Peter Melnyk
Chief Commercial Officer

contact Novocure

Thank you for your interest in Novocure. Please click the link below and complete and submit the contact form, or use the company directory to find a specific business unit or location.

Contact